Latest Updates
-
Simple and Sweet Beetroot Juice Recipe for a Healthy Start -
Horoscope for Today June 13, 2026 - Steady Focus, Calm Progress -
El Nino 2026 Grows Stronger, India Faces Rising Monsoon Uncertainty And Heat Risks -
Creamy and Rich Paneer Lababdar Recipe: A Royal Delight -
Elon Musk Becomes World’s First Trillionaire After Historic SpaceX IPO, Net Worth Hits $1.1 Trillion -
Gujarati Style Ragda Patties Recipe: A Flavorful Indian Snack -
Who Was Jaspal Rana? Indian Sports Legend And Shooting Coach Passes Away At 49 -
New OTT Releases This Week: The Biggest Premieres On Netflix, Prime Video And JioHotstar -
Punjabi Style Aloo Puri Recipe: Your Ultimate Lunch Delight -
Adhik Krishna Rama-Lakshmana Dwadashi 2026: Significance, Timings, Rituals And Spiritual Benefits
Brain Imaging
Washington : In a move to develop a more personalised approach towards medication depending upon genetic information or other biological markers, researchers have shed light on the potential use of functional magnetic resonance imaging (fMRI) to match treatments for patients with generalized anxiety disorder (GAD).
“Personalized medicine" is required as individuals in different groups respond to medications differently not only from individuals of other groups but those of the same group as well.
The researchers led by Dr. Paul Whalen examined subjects diagnosed with GAD who underwent brain scans both before and after treatment with venlafaxine, an antidepressant that has been shown to be effective in treating anxiety. They later measured the participants" responses to viewing pictures of fearful facial expressions during the fMRI scans.
“We focused our study on a regulatory circuit in the brain involving the amygdala, an area that serves to detect the presence of threatening information, and the prefrontal cortex, an area that functions to control these threat responses when they are exaggerated or unnecessary," said Whalen.
The results indicated that almost two thirds of the patients found relief from their anxiety symptoms after treatment, and amongst those who improved, some responded better than others. And according to the hypothesis, the fMRI data predicted who would do well on the drug and who would not.
Whalen said: “subjects who showed high prefrontal cortex activation together with low amygdala activation in response to the fearful faces reported a significant decrease in their anxiety symptoms, while those showing the reverse brain activation pattern (i.e., high amygdala, low prefrontal) did not."
The study was published in Biological Psychiatry.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications